(Q36639094)

15 August 2017

1 reference

title

Neurocysticercosis: current knowledge and advances (English)

1 reference

15 August 2017

1 reference

Wayne X Shandera

1

1 reference

PubMed ID

17074279

15 August 2017

Joseph S Kass

series ordinal

2

1 reference

PubMed ID

17074279

15 August 2017

language of work or name

1 reference

1 November 2006

1 reference

Current Neurology and Neuroscience Reports

15 August 2017

1 reference

15 August 2017

6

1 reference

15 August 2017

6

1 reference

15 August 2017

453-459

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-006-0046-3

15 August 2017

0 references

cites work

Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-006-0046-3

Calcific neurocysticercosis and epileptogenesis.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-006-0046-3

Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11910-006-0046-3

Vaccination of pigs to control human neurocysticercosis

21 January 2018

1 reference

12 December 2020

Management of neurocysticercosis

1 reference

12 December 2020

Sequential expression of the neuropeptides substance P and somatostatin in granulomas associated with murine cysticercosis

1 reference

12 December 2020

Bruns syndrome caused by intraventricular neurocysticercosis treated using flexible endoscopy.

1 reference

12 December 2020

New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).

1 reference

12 December 2020

Is dementia reversible in patients with neurocysticercosis?

1 reference

12 December 2020

Current consensus guidelines for treatment of neurocysticercosis

1 reference

12 December 2020

Brain granulomas in neurocysticercosis patients are associated with a Th1 and Th2 profile

1 reference

12 December 2020

Short report: limited and short-lasting humoral response in Taenia solium: seropositive households compared with patients with neurocysticercosis.

1 reference

12 December 2020

Cellular immune responses in human neurocysticercosis

1 reference

12 December 2020

Epilepsy due to neurocysticercosis: analysis of 203 patients.

1 reference

12 December 2020

Genetic pattern of the HLA system: HLA A, B, C, DR, and DQ antigens in Mexican patients with parenchymal brain cysticercosis.

1 reference

12 December 2020

1 reference

12 December 2020

Cysticercosis in Los Angeles County

1 reference

12 December 2020

Neurocysticercosis in an Orthodox Jewish community in New York City

1 reference

12 December 2020

Neurocysticercosis in Houston, Texas. A report of 112 cases.

1 reference

12 December 2020

A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis

1 reference

12 December 2020

Albendazole trial at 15 or 30 mg/kg/day for subarachnoid and intraventricular cysticercosis.

1 reference

12 December 2020

Prevalence and risk of cysticercosis and taeniasis in an urban population of soldiers and their relatives.

1 reference

12 December 2020

One week versus four weeks of albendazole therapy for neurocysticercosis in children: a randomized, placebo-controlled double blind trial

1 reference

12 December 2020

Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County

1 reference

12 December 2020

Clinical aspects of neurocysticercosis

1 reference

12 December 2020

Cysticercosis: imported and autochthonous infections in Kuwait

1 reference

12 December 2020

Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence.

1 reference

12 December 2020

Therapy for neurocysticercosis

1 reference

12 December 2020

Eating habits of east Asian people and transmission of taeniasis

1 reference

12 December 2020

Recent advances in the diagnosis and treatment of cerebral cysticercosis

1 reference

12 December 2020

Neurocysticercosis: evaluation with advanced magnetic resonance techniques and atypical forms

1 reference

12 December 2020

Analysis of the peripheral immune response in patients with neurocysticercosis: evidence for T cell reactivity to parasite glycoprotein and vesicular fluid antigens.

1 reference

12 December 2020

Neurocysticercosis: updated concepts about an old disease

1 reference

12 December 2020

Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assay

1 reference

12 December 2020

Neurocysticercosis: management issues.

1 reference

12 December 2020

10.1007/S11910-006-0046-3

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17074279